C5-Binding Antibody Inhibits Complement Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The complement system, particularly the activation of Complement component 5 (C5), can lead to excessive immune responses and tissue damage, contributing to various diseases such as autoimmune disorders and hemolytic blood diseases, highlighting the need for a targeted therapeutic approach to modulate its activity.
Innovation Solution
Development of a C5-binding antibody or antigen-binding fragment that specifically inhibits C5 activation by binding to the C5 protein, particularly the beta chain's MG4 domain, to prevent or treat complement-related diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the complement system is activated to fight infection, then immune response is enhanced, but tissue damage and abnormal immune response occur
Solution Approach 1:
The patent uses a specific antibody as an intermediary molecule that binds to C5 and modulates its activation. The antibody acts as a mediator between the complement system and the pathogen, allowing controlled immune response while preventing uncontrolled tissue damage through selective inhibition of C5 convertase activity
Solution Approach 2:
The invention changes the activation parameters of the complement system by introducing an antibody that specifically binds to C5 at the cleavage site. This modifies the kinetic and thermodynamic parameters of C5 activation, reducing the rate of C5a and C5b generation while maintaining necessary immune function
2Productivity
If C5 convertase cleaves C5 to activate complement, then pathogen elimination is enhanced, but excessive immune response and inflammation occur
Solution Approach 1:
The patent extracts or removes the harmful excessive activation of C5 by using an antibody that specifically binds to and inhibits C5 convertase. This selective extraction of C5 activation prevents the generation of excessive C5a and C5b while preserving necessary complement function for pathogen elimination
3Reliability
If complement activation occurs to destroy infection source, then immune defense is strengthened, but autoimmune diseases and complement-related diseases are caused
Solution Approach 1:
The antibody serves as a protective intermediary that modulates complement activation. It binds to C5 and prevents uncontrolled activation that leads to autoimmune diseases, while still allowing sufficient complement activity for immune defense against infections
Solution Approach 2:
The patent applies preliminary anti-action by using an antibody that pre-binds to C5 and prevents its excessive activation before it can cause autoimmune damage. This preemptive inhibition blocks the formation of harmful C5a and C5b while maintaining necessary immune function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The C5-binding antibody effectively inhibits complement activation, offering a therapeutic solution for diseases associated with excessive C5 activity, including autoimmune and inflammatory conditions, by specifically targeting and binding to the C5 protein, thereby reducing tissue damage and immune response dysregulation.
Implementation Method 1
The C5-binding antibody or antigen-binding fragment specifically binds to the C5 protein, particularly the beta chain's MG4 domain, to prevent or treat complement-related diseases
Data Source
AI summary
The present invention relates to an antibody against C5, and a method for preventing and treating complement-related diseases using the antibody, wherein the antibody against C5 is effectively usable in preventing and treating complement-related diseases by inhibiting complement activation.